Fennec Pharmaceuticals Inc. (FENC) financial statements (2021 and earlier)

Company profile

Business Address PO BOX 13628
RESEARCH TRIANGLE PARK, NC 27709
State of Incorp. BC
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments30142328412
Cash and cash equivalents30142328412
Prepaid expense1000000
Other current assets0000000
Total current assets:31142328412
Noncurrent Assets
Other undisclosed noncurrent assets 0     
Total noncurrent assets: 0     
TOTAL ASSETS:31142328412
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2221000
Accounts payable2211000
Accrued liabilities1111000
Derivative instruments and hedges, liabilities   0001
Total current liabilities:2222002
Noncurrent Liabilities
Total liabilities:2222002
Stockholders' equity
Stockholders' equity attributable to parent29122127411
Common stock141106106103756969
Additional paid in capital49484544424242
Accumulated other comprehensive income1111111
Accumulated deficit(162)(144)(131)(121)(114)(112)(111)
Total stockholders' equity:29122127411
TOTAL LIABILITIES AND EQUITY:31142328412

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Operating expenses(18)(13)(10)(7)(3)(2)(3)
Other undisclosed operating income0      
Operating loss:(18)(13)(10)(7)(3)(2)(3)
Nonoperating income (expense)(0)01(0)011
Investment income, nonoperating0000000
Other nonoperating income (expense)(0)(0)0(0)(0)  
Interest and debt expense(0)(0)     
Net loss:(19)(13)(10)(7)(3)(1)(2)
Other undisclosed net income attributable to parent00     
Net loss available to common stockholders, diluted:(18)(13)(10)(7)(3)(1)(2)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(19)(13)(10)(7)(3)(1)(2)
Comprehensive loss, net of tax, attributable to parent:(19)(13)(10)(7)(3)(1)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: